VLTO Veralto

Q3 2025 10-Q

Filed: Jul 28, 2025Period ending Jul 4, 2025

Health Care

Instruments For Meas & Testing of Electricity & Elec SignalsSEC EDGAR

Veralto (VLTO) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Jul 28, 2025 for the fiscal period ending Jul 4, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q3 2025 10-Q

Risk Factors

• New insider trading risk: CEO adopted Rule 10b5-1 trading plan to sell 31,938 shares from May 28, 2025, to May 29, 2026
• No material updates to risk factors disclosed this quarter per filing statements

+3 more insights

Quarterly Financial Summary
XBRL

Revenue

$1.4B

Net Income

$239M

Net Margin

17.0%

Source: XBRL data from Veralto Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.

Other Veralto Quarterly Reports

Q4 2025 10-Q

Q2 2025 10-Q

Get deeper insights on Veralto

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.